Hypertension, left ventricular hypertrophy, and sudden death Lwin Lwin TinD. Gareth BeeversGregory Y. H. Lip OriginalPaper Pages: 449 - 457
Proteinuria: An underappreciated risk factor in cardiovascular disease Julián SeguraCarlos CampoLuis M. Ruilope OriginalPaper Pages: 458 - 462
Systolic versus diastolic blood pressure versus pulse pressure William B. White OriginalPaper Pages: 463 - 467
Why β-blockers are not cardioprotective in elderly patients with hypertension Ehud GrossmanFranz H. Messerli OriginalPaper Pages: 468 - 473
Are all antihypertensive drug classes equal in reducing left ventricular hypertrophy? Erwin H. FleischmannRoland E. Schmieder OriginalPaper Pages: 474 - 478
Vasodilatory edema: A common side effect of antihypertensive therapy Franz H. Messerli OriginalPaper Pages: 479 - 482
Hypertriglyceridemia and risk of coronary heart disease John E. Hokanson OriginalPaper Pages: 488 - 493
Dyslipidemia of the metabolic syndrome Giacomo RuotoloBarbara V. Howard OriginalPaper Pages: 494 - 500
The effects of errors in lipid measurement and assessment Gerald R. CooperGary L. MyersParvin P. Waymack OriginalPaper Pages: 501 - 507
Genetics, the environment, and lipid abnormalities Jose M. OrdovasHaiqing Shen OriginalPaper Pages: 508 - 513
Insulin resistance, diabetes, and atherosclerosis: Thiazolidinediones as therapeutic interventions Annaswamy RajiJorge Plutzky OriginalPaper Pages: 514 - 521